0000-0002-4153-8056 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity Save
- Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts☆ Save
- The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells Save
- Transcriptomic and epigenetic profiling of neuroblastoma states in response to RBM39 degrader Save
- Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma Save
- A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics Save
- Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma Save
- The Oligostilbene Gnetin H Is a Novel Glycolysis Inhibitor That Regulates Thioredoxin Interacting Protein Expression and Synergizes with OXPHOS Inhibitor in Cancer Cells Save
- Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma Save
- Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models Save